BREAST CANCER

September 10, 2021

Assessing Fulvestrant and Trastuzumab in HER2-Positive Advanced BC

September 10, 2021

Link Between Breast Cancer and Viruses?

September 10, 2021

No Benefit From Anthracyclines in ERBB2-Positive BC Treated with Dual ERBB2 Blockage

August 13, 2021

Racial and Ethnic Differences in Treatment and Survival of Women With TNBC

August 13, 2021

Celecoxib Safe, but Not Effective, for Breast Cancer

August 13, 2021

25-Year Survival Data on Tamoxifen in ER+/ERBB2-Negative BC

July 8, 2021

Choosing Between an Aromatase Inhibitor or Tamoxifen in Perimenopausal Patients

July 8, 2021

Assessing the Efficacy and Safety of PARP Inhibitors in Breast Cancer

July 8, 2021

Statins May Lower HF Risk in BC Patients on Anthracycline Chemotherapy

June 11, 2021

Breast Cancer: Not Just a Female Disease

June 4, 2021

Preventing Breast Cancer in High-Risk Patients

June 4, 2021

Progesterone Receptor–Negative Breast Cancer Predicts Worse Outcome

June 4, 2021

Is the 21-Gene Assay Useful in Predicting Endocrine Therapy Response?

September 2021

September 2021

In This Issue Digital Magazine Archives Subscription

Copyright © 2000 - 2021 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.